About this trial
Prospective cohort multicentric study including infertile patients undergoing a pregnancy test on βhCG day (around ET +11), after an ET in the context of an artificial cycle and receiving LPS with vaginal natural progesterone following the clinical practice in IVI RMA (Spain).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
The subject must provide written informed consent prior to any study related procedures
Women ≤50 years old
BMI ≤ 35 kg/m2
Adequate endometrial thickness (>6.5mm) and pattern (Triple A structure) in the proliferative phase
Disqualifiers
Uterine Pathology, adnexal pathology
Systemic diseases
Trial population
All infertile patients undergoing an embryo transfer in the context of an artificial cycle will be recruited.
Trial design
Cohort
Prospective
Treatments tested in this trial
BLOOD COLLECTION FOR P4 DETERMINATION
Procedure/SurgerySerum progesterone levels on the pregnancy test day
Treatment groups
Trial outcomes
Primary outcomes
LIVE BIRTH
Record of live birth existence
ONGOING PREGNANCY
Pregnancy confirmation by the observation of the presence of at least one gestational sac on ultrasound
POSITIVE PREGANCY
Measurement of pregnancy test results
BIOCHEMICAL MISCARRIAGE
Measurement of existence of miscarriage after a positive pregnancy test
Secondary outcomes
SERUM P4 LEVEL ON B-HCG DAY
Measurement of serum progesterone levels on the pregnancy test day
Sponsors and contacts
Click on the lead sponsor to view all of their trials.